Casado, Antonio <br/><br/>
Trabectedin for reversing platinum resistance and resensitization to platinum in patients with recurrent ovarian cancer.  [electronic resource] 

 -  Future oncology (London, England)  Jan 2019 
 - 271-280 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1744-8301 
<br/><br/><label>Standard No.: </label>10.2217/fon-2018-0554  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Clinical Trials as Topic<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Drug Resistance, Neoplasm--drug effects<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Ovarian Neoplasms--drug therapy<br/>Platinum--administration & dosage<br/>Retrospective Studies<br/>Trabectedin--administration & dosage